Survey on Orally Disintegrating Tablets
Not Applicable
Recruiting
- Conditions
- Type 2 diabetesD003924
- Registration Number
- JPRN-jRCT1030230612
- Lead Sponsor
- Sasaki Kazuyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
People who registered in Pep Up, a PHR service for health insurance societies, provided by JMDC
- People who have consented to participate in this research
Of these, the primary and secondary outcome analysis populations are people who have used orally disintegrating tablets and are confirmed to be people with type 2 diabetes. The target sample size of these people is 400.
Exclusion Criteria
- People who belong to the health insurance society of Mitsubishi Tanabe Pharma
- People who belong to the health insurance society that do not participate in this research
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of people satisfied with orally disintegrating tablets in non-elderly people with type 2 diabetes
- Secondary Outcome Measures
Name Time Method Odds Ratio of factors for satisfaction/dissatisfaction with orally disintegrating tablets in non-elderly people with type 2 diabetes